IP Library Granted Patent US 8,350,073
Granted Patent B2
US 8,350,073 · App. 13/033,472 · Granted Jan 8, 2013

Olefin metathesis catalysts and related methods

Assignee: Massachusetts Institute of Technology
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,350,073
App. No.
13/033,472
Granted
Jan 8, 2013
Kind
B2
Abstract

The present invention provides methods for the synthesis of catalysts and precursors thereof. Methods of the invention may comprise combining a catalyst precursor and at least one ligand to generate a catalytically active species, often under mild conditions and in high yields. In some cases, a wide variety of catalysts may be synthesized from a single catalyst precursor. Methods of the invention may also include the preparation of catalysts which, under reaction conditions known in the art, may have been difficult or impossible to prepare and/or isolate due to, for example, steric crowding at the metal center. The present invention also provides catalyst compositions, and precursors thereof, which may be useful in various chemical reactions including olefin metathesis. In some cases, methods of the invention may reduce the number of synthetic and purification steps required to produce catalysts and/or other reaction products, as well as reducing time, cost, and waste production.

Claims (25)

1. A compound of formula:

wherein:

M is Mo or W;

R 1 is an optionally substituted alkyl group;

R 2 and R 3 can be the same or different and are hydrogen, or an optionally substituted group selected from alkyl, heteroalkyl, aryl, or heteroaryl; and

R 6 and R 7 can be the same or different and are an optionally substituted group selected from heteroalkyl or heteroaryl, or R 6 and R 7 are joined together to form an optionally substituted bidentate ligand with respect to M; and wherein at least one of R 6 and R 7 is an oxygen-containing ligand, wherein said compound is other than

2. The compound according to claim 1 , wherein each of R 6 and R 7 is an oxygen-containing ligand.

3. The compound according to claim 1 , wherein the oxygen-containing ligand coordinates M via an oxygen atom.

4. The compound according to claim 3 , wherein R 6 and R 7 are joined together to form a biphenolate or binaphtholate ligand.

5. The compound according to claim 1 , wherein R 1 is optionally substituted adamantyl.

6. The compound according to claim 3 , wherein one of R 2 and R 3 is hydrogen and the other of R 2 and R 3 is an optionally substituted group selected from alkyl, heteroalkyl, aryl, or heteroaryl.

7. The compound according to claim 3 , wherein:

M is Mo;

R 2 is optionally substituted alkyl; and

R 3 is hydrogen.

8. The compound according to claim 3 , wherein:

M is W;

R 2 is optionally substituted alkyl; and

R 3 is hydrogen.

9. The compound according to claim 3 , wherein the oxygen-containing ligand is chiral.

10. The compound according to claim 3 , wherein R 6 and R 7 are taken together to form an optionally substituted bidentate ligand with M wherein the bidentate ligand is chiral.

11. A compound selected from:

or Mo(N-2,6-Br 2 -4-MeC 6 H 2 )(CHCMe 3 )[rac-Biphen], wherein Biphen is 3,3′-di-t-butyl-5,5′,6,6′-tetramethyl-1,1′-biphenyl-2,2′-diolate.

12. The compound according to claim 1 , wherein M is Mo.

13. The compound according to claim 1 , wherein M is W.

Assignments (2)
CONFIRMATORY LICENSE Recorded Sep 17, 2012
From: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 028995/0588 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 14, 2011
From: HOCK, ADAM S.; SCHROCK, RICHARD R.
To: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Reel/Frame 026438/0011 →
Continuity (2)
Continuation 11603951 · Nov 22, 2006
Related Publication 20110237815A1 · Sep 29, 2011